Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novaled is a leading developer of proprietary technologies and materials for organic light-emitting diodes (OLEDs) and organic electronics. The company's core PIN OLED technology significantly improves the power efficiency and operational lifetime of OLED devices, making it a critical partner for display and lighting manufacturers. In the healthcare sector, Novaled's technology is applied to the development of flexible, wearable OLED patches for photodynamic therapy (PDT), which are used to treat skin conditions such as actinic keratosis and non-melanoma skin cancer. Since its acquisition by Samsung in 2013, Novaled has operated as a specialized subsidiary focused on advanced organic materials and device architectures for both consumer electronics and medical applications. The company is headquartered in Dresden, Germany, and remains a key innovation hub within the global organic electronics industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novaled.